Y. Liu

Xinjiang Medical University

H指数:8

被引数:287

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Role of c-Myc-regulated miR-196a-5p in the progression of triple-negative breast cancer: Potential involvement of HOXA7 and HOXB7

c-Myc调控的miR-196a-5p在 triple-negative breast cancer 进展中的作用：HOXA7和HOXB7的潜在参与

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

IF1.9

2025-12-010

PRE

Oligo-CALL: A next-generation barcoding platform for studying resistance to targeted therapy

Oligo-CALL：一种用于研究靶向治疗耐药性的下一代条码平台

Science Advances

IF12.5

2025-11-070

PRE

c-Myc knockdown restores tamoxifen sensitivity in triple-negative breast cancer by reactivating the expression of ERα: the central role of miR-152 and miR-148a

BREAST CANCER

IF2.9

2025-03-010

PRE

Characterization of tumour heterogeneity through segmentation-free representation learning on multiplexed imaging data

通过无分割表示学习对多重成像数据进行肿瘤异质性表征

NATURE BIOMEDICAL ENGINEERING

IF26.6

2025-02-200

PRE

Role of Harmaline in Inhibiting c-Myc, Altering Molecular Typing, and Promoting Apoptosis in Triple-Negative Breast Cancer

breast cancer

IF3.4

2024-12-010

OAAI

Targeting ribosome biogenesis as a novel therapeutic approach to overcome EMT-related chemoresistance in breast cancer

ELIFE

IF0

2024-09-112

Preliminary results from a phase Ib study of amulirafusp alfa (IMM0306) in combination with lenalidomide in patients with relapsed or refractory CD20-positive B-cell nonHodgkin's lymphoma

Ib期研究初步结果：评估amulirafusp alfa（IMM0306）联合lenalidomide治疗复发或难治性CD20阳性B细胞非霍奇金淋巴瘤患者的疗效。

ANNALS OF ONCOLOGY

IF65.4

2024-09-011

PRE

Chemotherapy remodels the tumor immune microenvironment to increase the pCR rate of anti-PD-1 neoadjuvant therapy in MSS/pMMR locally advanced colon cancer: A prospective clinical trial and translational study

化疗重塑肿瘤免疫微环境，以增加MSS/pMMR局部晚期结肠癌中抗PD-1新辅助疗法的pCR率：一项前瞻性临床研究及转化研究

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

Camrelizumab plus apatinib as maintenance treatment in patients with extensive-stage small cell lung cancer who were responding or stable after standard first-line chemotherapy (CAMERA): Results from a single-arm, phase II trial

ANNALS OF ONCOLOGY

IF65.4

2023-11-010

PRE

Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy

CANCER RESEARCH

IF16.6

2023-09-2030

Germline mutations in DNA damage repair genes in patients with small cell lung cancer

ANNALS OF ONCOLOGY

IF65.4

2021-09-010

OAAI

Clinical utility of ctDNA and CTCs for genomic profiling and monitoring chemotherapy response in patients with small cell lung cancer

ANNALS OF ONCOLOGY

IF65.4

2020-09-010

OAAI

A novel methodology in producing clinical scaled tumour-infiltrating lymphocytes across multiple gynecological tumours

ANNALS OF ONCOLOGY

IF65.4

2020-09-010

OAAI

Delay in Initiating Chemotherapy Beyond 8 Weeks After Breast-Conserving Surgery is Associated with Inferior Survival Outcome for Early-stage Breast Cancer

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2019-09-010

PREAI

Risk Stratification Model for Prediction of Locoregional Recurrence in Patients with Pathologic T1-2N0 Breast Cancer after Mastectomy

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2019-09-010

OAAI

Recurrence Score Helps in Selecting T1-2N1 Breast Cancer Patients for Individualized Postmastectomy Radiotherapy - Joint Analysis of 2793 Patients from Two Institutions

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2019-09-010

OAAI

Radiotherapy Plays an Important Role in Improving the Survival Outcome in Patients with T1-2N1M0 Breast Cancer - A Joint Analysis of 4209 Real-world Cases from Two Institutions.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2019-09-010

OAAI

Modeling and Validation of a Nomogram to Predict N2 or N3 Disease in Breast Cancer Patients with One to Three Sentinel Lymph Nodes

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2019-09-010

OAAI

Chest Wall and Supraclavicular/Infraclavicular Nodal Region are Common Sites of Locoregional Recurrence for Women with Breast Cancer after Mastectomy Irrespective of TN Stage or Molecular Subtypes

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2019-09-010

PREAI

Breast Conservation Therapy Achieved Comparable Outcomes with Mastectomy in Patients with T1-2N0 Triple-Negative Breast Cancer: Analysis of 822 Patients in a Single Institution

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2018-11-010

OAAI

Y. Liu

个人简介

教育背景

工作经历

荣誉奖项

研究方向